These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30276823)

  • 21. Experimental Chagas disease in Balb/c mice previously vaccinated with T. rangeli. II. The innate immune response shows immunological memory: reality or fiction?
    Basso B; Marini V
    Immunobiology; 2015 Mar; 220(3):428-36. PubMed ID: 25454810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental Chagas disease. Innate immune response in Balb/c mice previously vaccinated with Trypanosoma rangeli. I. The macrophage shows immunological memory: Reality or fiction?
    Basso B; Marini V
    Immunobiology; 2014 Apr; 219(4):275-84. PubMed ID: 24321621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of nitric oxide (NO) and TNF-alpha in the oxidative stress associated with anemia in experimental Trypanosoma cruzi infection.
    Malvezi AD; Cecchini R; de Souza F; Tadokoro CE; Rizzo LV; Pinge-Filho P
    FEMS Immunol Med Microbiol; 2004 May; 41(1):69-77. PubMed ID: 15094169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of Galectin-3 Prevents Cardiac Fibrosis and Effective Immune Responses in a Murine Model of Trypanosoma cruzi Infection.
    Pineda MA; Cuervo H; Fresno M; Soto M; Bonay P
    J Infect Dis; 2015 Oct; 212(7):1160-71. PubMed ID: 25805753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoregulatory mechanisms in Chagas disease: modulation of apoptosis in T-cell mediated immune responses.
    Chaves AT; de Assis Silva Gomes Estanislau J; Fiuza JA; Carvalho AT; Ferreira KS; Fares RC; Guimarães PH; de Souza Fagundes EM; Morato MJ; Fujiwara RT; da Costa Rocha MO; Correa-Oliveira R
    BMC Infect Dis; 2016 Apr; 16():191. PubMed ID: 27138039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trypanosoma cruzi Produces the Specialized Proresolving Mediators Resolvin D1, Resolvin D5, and Resolvin E2.
    Colas RA; Ashton AW; Mukherjee S; Dalli J; Akide-Ndunge OB; Huang H; Desruisseaux MS; Guan F; Jelicks LA; Matos Dos Santos F; Nagajyothi J; Zingman MA; Reyes J; Weiss LM; Serhan CN; Tanowitz HB
    Infect Immun; 2018 Apr; 86(4):. PubMed ID: 29358332
    [No Abstract]   [Full Text] [Related]  

  • 27. Altered pattern of connectivity in Chagas disease.
    Pavón-Martínez N; Masso-Rojas F; López-Alcántara R; Monteón VM
    Ann N Y Acad Sci; 2007 Jun; 1107():271-9. PubMed ID: 17804555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A therapeutic nanoparticle vaccine against Trypanosoma cruzi in a BALB/c mouse model of Chagas disease.
    Barry MA; Wang Q; Jones KM; Heffernan MJ; Buhaya MH; Beaumier CM; Keegan BP; Zhan B; Dumonteil E; Bottazzi ME; Hotez PJ
    Hum Vaccin Immunother; 2016 Apr; 12(4):976-87. PubMed ID: 26890466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunity and immune modulation in Trypanosoma cruzi infection.
    Cardillo F; de Pinho RT; Antas PR; Mengel J
    Pathog Dis; 2015 Dec; 73(9):ftv082. PubMed ID: 26438729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current concepts in immunoregulation and pathology of human Chagas disease.
    Dutra WO; Gollob KJ
    Curr Opin Infect Dis; 2008 Jun; 21(3):287-92. PubMed ID: 18448974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of repetitive stress during the acute phase of Trypanosoma cruzi infection on chronic Chagas' disease in rats.
    Caetano LC; Brazão V; Filipin Mdel V; Santello FH; Caetano LN; Toldo MP; Caldeira JC; do Prado JC
    Stress; 2009 Mar; 12(2):144-51. PubMed ID: 18850489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rat models to investigate host macrophage defense against Trypanosoma cruzi.
    Fabrino DL; Leon LL; Genestra M; Parreira GG; Melo RC
    J Innate Immun; 2011; 3(1):71-82. PubMed ID: 21051863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolution and pathology in chagas disease--a review.
    Teixeira AR; Nascimento RJ; Sturm NR
    Mem Inst Oswaldo Cruz; 2006 Aug; 101(5):463-91. PubMed ID: 17072450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of Toll-like receptors and adaptive immunity in the development of protective or pathological immune response triggered by the Trypanosoma cruzi protozoan.
    Pellegrini A; Guiñazu N; Giordanengo L; Cano RC; Gea S
    Future Microbiol; 2011 Dec; 6(12):1521-33. PubMed ID: 22122446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PPARγ ligand treatment inhibits cardiac inflammatory mediators induced by infection with different lethality strains of Trypanosoma cruzi.
    Penas F; Mirkin GA; Hovsepian E; Cevey A; Caccuri R; Sales ME; Goren NB
    Biochim Biophys Acta; 2013 Jan; 1832(1):239-48. PubMed ID: 22917565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute Chagas' disease: immunohistochemical characteristics of T cell infiltrate and its relationship with T. cruzi parasitic antigens.
    Fuenmayor C; Higuchi ML; Carrasco H; Parada H; Gutierrez P; Aiello V; Palomino S
    Acta Cardiol; 2005 Feb; 60(1):33-7. PubMed ID: 15779849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The lysis of Trypanosoma cruzi epimastigotes by eosinophils and neutrophils.
    López AF; Moreno MM; Sanderson CJ
    Int J Parasitol; 1978 Dec; 8(6):485-9. PubMed ID: 107139
    [No Abstract]   [Full Text] [Related]  

  • 38. The innate immune response to Trypanosoma cruzi infection.
    Kayama H; Takeda K
    Microbes Infect; 2010 Jul; 12(7):511-7. PubMed ID: 20348008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiprotozoal drug nitazoxanide enhances parasitemia, tissue lesions and mortality caused by Trypanosoma cruzi in murine model.
    Valle-Reyes JS; Melnikov V; Dobrovinskaya O; Rodriguez-Hernández A; Wookee-Zea C; Pimientel-Rodrigez V; Rueda-Valdovinos G; Delgado-Enciso I; López-Lemus UA; Espinoza-Gómez F
    Exp Parasitol; 2017 Jan; 172():44-50. PubMed ID: 28011170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccination with Trypanosoma rangeli induces resistance of guinea pigs to virulent Trypanosoma cruzi.
    Basso B; Moretti E; Fretes R
    Vet Immunol Immunopathol; 2014 Jan; 157(1-2):119-23. PubMed ID: 24275040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.